Assignee
CTI BIOPHARMA CORP
US·4 granted patents·5 pending applications·4 citations·filing 2013–2021
Top patents by PatentIndex Score
9 records- 0177US9573964B2Oxygen linked pyrimidine derivativesCTI BIOPHARMA CORP·Filed 2013·Granted Feb 21, 2017·3 cites·48 claims
- 0273US10517876B2Oxygen linked pyrimidine derivativesCTI BIOPHARMA CORP·Filed 2017·Granted Dec 31, 2019·1 cites·42 claims
- 0370US11135227B2Oxygen linked pyrimidine derivativesCTI BIOPHARMA CORP·Filed 2019·Granted Oct 5, 2021·0 cites·19 claims
- 0467US2022241291A1Oxygen linked pyrimidine derivativesCTI BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 0559US2022008448A1Methods of treating flt3-mutated hematologic cancersCTI BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 0655US2021069199A1Methods of treating transplant rejectionCTI BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 0754US2016256557A1Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activityCTI BIOPHARMA CORP·Filed 2015·Application pending·0 cites
- 0848US2018318306A1Methods of treating transplant rejectionCTI BIOPHARMA CORP·Filed 2016·Application pending·0 cites
- 0939US9624242B211-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate saltCTI BIOPHARMA CORP·Filed 2015·Granted Apr 18, 2017·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when CTI BIOPHARMA CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →